Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound 10b as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, > 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu 2+ chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aβ25−35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, melatonin and ferulic acid, suggesting potentially disease-modifying properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Improved protein–ligand docking using GOLD
Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10465 · Cited by 3,067
Ou, B., Hampsch-Woodill, M., & Prior, R. L. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010586o · Cited by 2,932
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
DPPH antioxidant assay revisited
Sharma, O. P., & Bhat, T. K. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2008.08.008 · Cited by 1,969
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC−Fluorescein) Assay
Dávalos, A., Gómez-Cordovés, C., & Bartolomé, B. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0305231 · Cited by 1,207
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Ho, T. C. S., Chan, A. H. Y., & Ganesan, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00830 · Cited by 795
Santo, L., Hideshima, T., Kung, A. L., Tseng, J.-C., Tamang, D., Yang, M., Jarpe, M., van Duzer, J. H., Mazitschek, R., Ogier, W. C., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387365 · Cited by 616
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 521
Self-citation
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“513 Compound 39 achieved strong HDAC6 selectivity through interaction with another speci fi c pocket on HDAC6, inhibiting tau hyperphosphorylation and aggregation.”
BackgroundMelatonin in Cancer Treatment: Current Knowledge and Future Opportunities
Talib, W. H., Alsayed, A. R., Abuawad, A., Daoud, S., & Mahmod, A. I. (2021) · Molecules · doi:10.3390/molecules26092506 · Cited by 210
“Besides, it shows immunomodulation and neuroprotective potential in a pharmacological Alzheimer’s disease mouse model [41].”
BackgroundZhang, H., Zhang, Y., Li, Y., Wang, Y., Yan, S., Xu, S., Deng, Z., Yang, X., Xie, H., & Li, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756550 · Cited by 104
Li, Y., Sang, S., Ren, W., Pei, Y., Bian, Y., Chen, Y., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113874 · Cited by 77
Photoinduced ynamide structural reshuffling and functionalization
Mutra, M. R., & Wang, J. (2022) · Nature Communications · doi:10.1038/s41467-022-30001-7 · Cited by 51
Zang, W.-B., Wei, H., Zhang, W., Ma, W., Li, J., & Yao, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116070 · Cited by 50
Long, Y., Li, D., Yu, S., Shi, A., Deng, J., Wen, J., Li, X., Ma, Y., Yu-lu, Z., Liu, S., et al. (2022) · Food & Function · doi:10.1039/d2fo01287a · Cited by 45
The Genus Alternanthera: Phytochemical and Ethnopharmacological Perspectives
Singla, R. K., Dhir, V., Madaan, R., Kumar, D., Bola, S. S., Bansal, M., Kumar, S., Dubey, A. K., Singla, S., & Shen, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.769111 · Cited by 44
Wang, H., Wang, H., Huang, H., Qu, Z., Ma, D., Dang, X., & Dong, Q. (2022) · Cells · doi:10.3390/cells11182809 · Cited by 43
Research progress of natural products and their derivatives against Alzheimer’s disease
Liu, J., Guo, H., Quan, Z., Shen, Q., Cui, H., & Li, X. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2171026 · Cited by 39
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Singh, Y. P., & Kumar, H. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14638 · Cited by 38
“Many groups have effectively explored ferulic acid nucleus as a lead multifunction agent for the management of AD (He et al. 2021; Liu et al. 2017; Rosini et al. 2019; Sang et al. 2019; Singh, Shankar, et al. 2021).”
Canet, G., Zussy, C., Hernandez, C., Maurice, T., Desrumaux, C. M., & Givalois, L. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108398 · Cited by 36
Self-citationCifuentes, J., Salazar, V. A., Cuellar, M., Castellanos, M. C., Rodríguez, J., Cruz, J. C., & Muñoz-Camargo, C. (2021) · Antioxidants · doi:10.3390/antiox10071040 · Cited by 35
Rampelotto, C. R., Pereira, V. G., SILVEIRA, L. D. S., Rossato, A., Machado, A. K., Sagrillo, M. R., Gündel, A., Bürger, M. E., Schaffazick, S. R., & da Silva, C. D. B. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105259 · Cited by 28
Liang, T., Xie, Z., Dang, B., Wang, J., Zhang, T., Luan, X., Lu, T., Cao, C., & Chen, X. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129148 · Cited by 27
Galvani, F., Cammarota, M., Vacondio, F., Rivara, S., & Boscia, F. (2024) · Journal of Pineal Research · doi:10.1111/jpi.70008 · Cited by 25
Lü, X., Qin, N., Liu, Y., Du, C., Feng, F., Liu, W., Chen, Y., & Sun, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114729 · Cited by 24
Wang, X.-X., Xie, F., Jia, C.-C., Yan, N., Zeng, Y.-L., Wu, J.-D., & Liu, Z.-P. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113821 · Cited by 23
Rehman, M. U., Zuo, Y., Tu, N., Guo, J., Liu, Z., Cao, S., & Long, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117350 · Cited by 23
Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Gu, Z., Lin, S., Yu, J., Jin, F., Zhang, Q., Xia, K., Chen, L., Li, Y., & He, B. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116571 · Cited by 24
Design, Synthesis, and biological evaluation of HDAC6 inhibitors based on Cap modification strategy
Li, X., Liu, X., Wang, S., Shi, X., Lü, M., Hao, X., Fu, Y., Zhang, Y., Jia, Q., & He, D. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105874 · Cited by 21
Kunnummal, S. P., & Khan, M. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03247-0 · Cited by 21
“In another study, melatonin and FA-derived tertiary amide-based histone Deacetylase 6 (9HDAC-6) structure was used as multi-target inhibitors for neurodegenerative diseases [106].”
Pont, C., Ginex, T., Griñán‐Ferré, C., Scheiner, M., Mattellone, A., Martínez, N., Arce, E. M., Soriano-Fernández, Y., Naldi, M., Simone, A. D., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113779 · Cited by 20
Self-citationWang, L., Sun, T., Wang, Z., Liu, H., Qiu, W., Tang, X., Guo, H., Yang, P., Yao, C., & Sun, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00358 · Cited by 20
Singh, G., Kumar, S., Panda, S. R., Kumar, P., Rai, S., Verma, H., Singh, Y. P., Kumar, S., Srikrishna, S., Naidu, V. G. M., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00130 · Cited by 20
Gu, X. Q., Zhang, H., Jiao, M.-R., Han, B. R., Zhang, Z., Li, J., & Zhang, Q. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114090 · Cited by 19
Неганова, М. Е., Aleksandrova, Y. R., Суслов, Е. В., Mozhaitsev, E. S., Munkuev, A. A., Tsypyshev, D. O., Chicheva, M. M., Rogachev, A. D., Sukocheva, O. A., Volcho, K. P., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111893 · Cited by 17
Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach
Kumar, S., Mahajan, A. T., Ambatwar, R., & Khatik, G. L. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673264076230921065945 · Cited by 18
The roles of the circadian hormone melatonin in drug addiction
Jia, S., Guo, X., Chen, Z., Li, S., & Liu, X.-A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106371 · Cited by 19
Bendrihem, K. A., Mouane, A., Azzi, M., Mihoubi, M. A., Atanassova, M., SAWICKA, B. H., Zahnit, W., & Messaoudi, M. (2025) · Phytotherapy Research · doi:10.1002/ptr.8481 · Cited by 17
“In the realm of neuro-degenerative disorders, research has shown that merging FeA with melatonin to create HDAC6-selective inhibitors demonstrates significant neuroprotective effects in an Alzheimer's disease mouse model (He et al. 2021).”
The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases
Monayo, S. M., & Liu, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.867500 · Cited by 16
Helmi, Y. Y., Papenkordt, N., Rennar, G. A., Gbahou, F., ElHady, A. K., Labani, N., Schmidtkunz, K., Boettcher, S., Jockers, R., Abdel‐Halim, M., et al. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202300149 · Cited by 12
Du, L., Zheng, L.-Y., Pan, Y., Sheng, Z.-K., Zhang, S., Lin, H., Zhang, A., Xie, H.-J., & Luo, X. (2022) · Catalysts · doi:10.3390/catal12101265 · Cited by 11
Shankar, G., Kumar, C. P., Yadav, M., Ghosh, A., Panda, S. R., Banerjee, A., Tiwari, A. K., Rai, S., Kumar, S., Garg, P., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116959 · Cited by 11
Nutrigenomics: an underestimated contribution to the functional role of polyphenols
Dall’Asta, M., Barbato, M., Rocchetti, G., Rossi, F., Lucini, L., Ajmone‐Marsan, P., & Colli, L. (2022) · Current Opinion in Food Science · doi:10.1016/j.cofs.2022.100880 · Cited by 11
Li, Y., Yang, H., Zhao, X., Zhao, X., Quan, J., Wang, L., Ma, E., & Ma, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116608 · Cited by 9
Pang, L., Li, J., Liu, Z., Quan, Y., Sui, H., Jia, Y., Chen, F., Lee, J. J., Liu, P., Quan, Z., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114825 · Cited by 9
Pandurang, T. P., Kumar, B., Verma, N., Dastidar, D. G., Yamada, R., Nishihara, T., Tanabe, K., & Kumar, D. (2023) · ChemMedChem · doi:10.1002/cmdc.202200405 · Cited by 8
Wen, W., Hu, J., Wang, C., Yang, R., Zhang, Y., Huang, B., Qiao, T., Wang, J., & Chen, X. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129670 · Cited by 8
Liu, R., Guo, L., Zhao, Y., Yu, J., Yu, J., & Liu, P. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148847 · Cited by 7
Fang, L., Song, Y., Jin, H., Liu, Y., & Gou, S.-H. (2024) · Small · doi:10.1002/smll.202403625 · Cited by 10
Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer’s Disease
Liu, Y., Zhang, Z., Zhu, Z., Yang, Y., Peng, W., Chen, Q., Mak, S., Tsim, K. W. K., & Pi, R. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575330648240819112435 · Cited by 6
Joshi, N., Khadse, P., Jadhav, S., & Alavala, R. R. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266360664250606110220 · Cited by 6
Bedini, A., Boutin, J. A., Legros, C., Zlotos, D. P., & Spadoni, G. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12953 · Cited by 7
“…of melatonin, novel hybrid molecules [by linking melatonin to tacrine ( 17 ) and curcumin ( 18 ), or by chemically merging the structures of melatonin and ferulic acid into the HDAC6 inhibitor 19 , 123 Figure 4] have been proposed as putative therapeutic options for neurodegenerative disorders.”
BackgroundQuan, J., Ma, C., Zhao, X., Guo, Y., Qu, W., Zhou, X., Ma, E., & Xu, Y. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108360 · Cited by 6
Zhang, Z., Cheng, M., Guo, J., Wan, Y., Wang, R., Fang, Y., Jin, Y., Xie, S., & Liu, J. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.132319 · Cited by 7
Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
Zhang, T., Zhao, X., Sun, X., Tian, W., Wang, C., Wang, M., Zhang, Y., Chen, X., & Zheng, C. (2022) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2022.101450 · Cited by 6
Histone deacetylase 6 inhibitors in Alzheimer's disease therapy: structure design and challenges
Dang, B., Chen, H., Liu, S., Liu, H., Kang, Z., Yang, Z., Yang, W., Hu, J., & Chen, X. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130318 · Cited by 5
Role of Computational Modeling in Drug Discovery for Alzheimer’s Disease
Yadav, M. R., Murumkar, P. R., Barot, R. R., Yadav, R., Joshi, K. D., & Chauhan, M. (2023) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-031-33871-7_3 · Cited by 7
Marzouk, M. A., Greco, S., Gbahou, F., Küblbeck, J., Labani, N., Jockers, R., Holzgrabe, U., Wiesmüller, L., & Zlotos, D. P. (2024) · ACS Omega · doi:10.1021/acsomega.4c08881 · Cited by 4
Cell-Based Assays to Assess Neuroprotective Activity
Poeta, E., Massenzio, F., Babini, G., & Monti, B. (2024) · Neuromethods · doi:10.1007/978-1-0716-4232-0_10 · Cited by 3
Self-citationCao, R., Song, C., Wang, Z., Lv, B., Xiao, W. L., Chen, G., & Bao, X. (2025) · Molecular Diversity · doi:10.1007/s11030-024-11054-w · Cited by 1
“The analysis was carried out in tripli-cates and the IC 50 was determined using linear regression plots [26–28].”
He, F., Hofmann, J., Poeta, E., Monti, B., Crouzier, L., Maurice, T., & Decker, M. W. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118068 · Cited by 1
Self-citationPharmacological landscape of carbolines: a holistic view
Zhang, Y., Wu, F., Rehman, M. U., & Long, S. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00057f · Cited by 2
Chen, H., Li, Y., Liang, Z., Zhong, Z., Huang, Y., Liu, Z., Gu, Y., Jiang, L., Gan, C., & Gan, C. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106867 · Cited by 1
Histone Deacetylase Inhibitors: Design, Synthesis, and Biological Evaluation
Pulya, S., Ganorkar, A., Biswas, S., & Ghosh, B. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_16 · Cited by 1
Azirar, S., Lamtai, M., Hamzaoui, A. E., Brouzi, M. Y. E., Ibouzine‐Dine, L., Hessni, A. E., & Mesfioui, A. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01833-9
“MEL has demonstrated neuroprotective effects across a variety of conditions, including brain injury [63], heavy metal and pesticide toxicity [64–66], neurodegenerative diseases [67, 68], and chemotherapy-induced neurotoxicity [69].”
Shanmugam., M., Balamani, S., & Nihar, S. S. (2026) · International Journal of Research and Review · doi:10.52403/ijrr.20260110
Shen, S. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2676080
“…contains a melatonin-like moiety and a ferulic acid-like moiety to form a two-branched Cap, which was reported to attenuate spontaneous alternation deficits and long-term memory dysfunction in Aβ 25 − 35 peptide induced AD mice following repeated IP administration at 0.3 mg/kg/day for 7 days [150].”
InfluentialMelatonin hybrids as multifunctional therapeutic agents: A comprehensive review
Damirchi, E. K., Barani, A., Hamidi, S. M., & Ebrahimzadeh, M. A. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119156
BindingDB Entry 50022176: Advances in dual-targeting inhibitors of HDAC6 for cancer treatment.
BindingDB (2025) · UC San Diego · doi:10.7270/q24x5dg9
Metadata
- Authors
- He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., & Decker, M.
- Affiliations
- University of Würzburg (DE)
- Medical University of South Carolina (US)
- University of Bologna (IT)
- Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany
- Inserm (FR)
- Corresponding author
- Maurice, Tangui
- Decker, Michael
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-03-26
- Volume
- 64
- Issue
- 7
- Pages
- 3794-3812
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3136159689
- Cited by
- 66
- References
- 65
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 14 · 2021: 9
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Bundesministerium f?r Bildung und Forschung (57387204)
- Deutscher Akademischer Austauschdienst
- Campus France
- Deutsche Forschungsgemeinschaft (DE1546/6-3)
- Studienstiftung des Deutschen Volkes
- Bayerisch-Franz?sisches Hochschulzentrum (FK03-2020)
- China Scholarship Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- HDAC6 inhibitors, melatonin, ferulic acid, Alzheimer's disease, immunomodulation, neuroprotection, antioxidant activity, amyloid beta 25-35, spatial working memory, long-term memory, disease-modifying therapy, structure-activity relationship, HT22 cells
- MeSH terms
- Histone Deacetylase 6, Alzheimer Disease, Animals, Cell Line, Transformed, Coumaric Acids, Immunologic Factors, Male, Melatonin, Structure-Activity Relationship, Tryptamines, Neuroprotective Agents, Catalytic Domain, Mice, Histone Deacetylase Inhibitors, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.